Miriam Kim

Assistant Professor of Medicine

    • 147 Citations
    20132020

    Research output per year

    If you made any changes in Pure these will be visible here soon.

    Fingerprint Dive into the research topics where Miriam Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

    • 28 Similar Profiles

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output

    • 147 Citations
    • 6 Article
    • 1 Review article

    Human chimeric antigen receptor macrophages for cancer immunotherapy

    Klichinsky, M., Ruella, M., Shestova, O., Lu, X. M., Best, A., Zeeman, M., Schmierer, M., Gabrusiewicz, K., Anderson, N. R., Petty, N. E., Cummins, K. D., Shen, F., Shan, X., Veliz, K., Blouch, K., Yashiro-Ohtani, Y., Kenderian, S. S., Kim, M. Y., O’Connor, R. S., Wallace, S. R. & 6 others, Kozlowski, M. S., Marchione, D. M., Shestov, M., Garcia, B. A., June, C. H. & Gill, S., Aug 1 2020, In : Nature Biotechnology. 38, 8, p. 947-953 7 p.

    Research output: Contribution to journalArticle

  • 26 Scopus citations

    Unlabeled Competitor Antibody to Reduce Nonlinear Signal Spillover in Mass Cytometry

    Sekhri, P., Kim, M. Y. & Behbehani, G. K., Jan 1 2019, In : Cytometry Part A. 95, 8, p. 898-909 12 p.

    Research output: Contribution to journalArticle

  • Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia

    Kim, M. Y., Yu, K. R., Kenderian, S. S., Ruella, M., Chen, S., Shin, T. H., Aljanahi, A. A., Schreeder, D., Klichinsky, M., Shestova, O., Kozlowski, M. S., Cummins, K. D., Shan, X., Shestov, M., Bagg, A., Morrissette, J. J. D., Sekhri, P., Lazzarotto, C. R., Calvo, K. R., Kuhns, D. B. & 5 others, Donahue, R. E., Behbehani, G. K., Tsai, S. Q., Dunbar, C. E. & Gill, S., May 31 2018, In : Cell. 173, 6, p. 1439-1453.e19

    Research output: Contribution to journalArticle

    Open Access
  • 90 Scopus citations

    EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT

    Merchant, A. A., Jorapur, A., McManus, A., Liu, R., Krasnoperov, V., Chaudhry, P., Singh, M., Harton, L., Agajanian, M., Kim, M., Triche, T. J., Druker, B. J., Tyner, J. W. & Gill, P. S., Sep 12 2017, In : Blood Advances. 1, 20, p. 1635-1644 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • 12 Scopus citations

    Pharmacoeconomic implications of lenalidomide maintenance therapy in multiple myeloma

    Kim, M. Y., Sposto, R., Swaika, A., Asano, H., Alamgir, A., Chanan-Khan, A. & Ailawadhi, S., Nov 7 2014, In : Oncology (Switzerland). 87, 4, p. 224-231 8 p.

    Research output: Contribution to journalArticle

  • 10 Scopus citations